LEADING TECHNOLOGY FOR THE ENCAPSULATION OF NUCLEIC ACIDS, BIOMOLECULES AND OTHER APIs.
Our technology solves your current encapsulation challenges.Highly flexible GMP manufacturing solutions for your genetic payloads and other molecules.
Our solution
LEON has proven experience in developing state-of-the-art nanoparticle production processes, and technology for scale-up and commercial manufacturing. Commercial encapsulation of genetic biomolecules faces a big bottleneck. Current technologies have several limitations: they are overly complex, cumbersome, investment intensive, inefficient, and costly. LEON’s NANOnow solutions solve this bottleneck, making manufacturing of these products an affordable proposition.
Personalized medicine produced in minutes.
NANOme is a disruptive technology providing a closed device for advanced genetic product and individualized medicine manufacturing.
NANOme enables the encapsulation of genetic material into lipid nanoparticles in minutes instead of hours, with more control and at a significantly lower cost than current methods.
A new level of vaccine manufacturing.
The need for rapidly manufactured, large-scale quantities of vaccines has never been more immediate. NANOus disrupts current manufacturing processes and makes them faster and more cost-efficient than ever before.
LEON´s device platform for encapsulation of transfection material
NANOnow is LEON’s proprietary nano-encapsulation device platform that increases the efficiency of nanoparticle manufacturing. With an IP-protected reactor for the manufacturing of nanoparticles, we make fast and cost efficient GMP manufacturing of preventive therapies possible. From medium to large scale as well as single piece flow manufacturing of therapeutic personalized treatments.
And we are flexible: From surface stabilized polymeric nanoparticles to lipid nanoparticles and liposomes: Our technology is suitable for a wide range of particle types and application forms.
With NANOsolv we expedite APIs, revitalize forgotten formulations and breathe new life into generics to deliver improved stability, increased solubility and enhanced bioavailability.
Our solution is based on our proprietary technology, a classic bottom-up approach to the synthesis of SMART nanoparticles or microparticles.
